Acne vulgaris is a common inflammatory disorder of the pilosebaceous unit. In aesthetic practice, clients may present with comedones, papules, pustules, nodules, cysts, post-inflammatory pigmentation or established scarring, often alongside increased sebum production.
Practitioners can play an important role in recognising severity, supporting appropriate skincare and identifying when a client needs medical management. The aim of this page is therefore not to provide a treatment prescription, but to help practitioners assess the presentation and connect it to suitable professional products, training and referral pathways.
Understanding Acne Pathogenesis
Acne develops through several interacting processes: follicular hyperkeratinisation and blockage, increased sebum production, proliferation of Cutibacterium acnes within the follicle and inflammation. These processes can begin before a visible lesion appears, which is why effective management usually requires consistency rather than spot-by-spot intervention.
Hormonal influences, genetics, some medicines and occlusive or frictional factors may contribute in individual clients. Diet and stress are often discussed by clients, but practitioners should avoid presenting single lifestyle factors as the universal cause of acne.
How Acne May Present
-
Open comedones (blackheads)
-
Closed comedones (whiteheads)
-
Inflammatory papules
-
Pustules
-
Nodules or cysts that are deeper, painful and more likely to scar
-
Post-inflammatory erythema or hyperpigmentation after active lesions resolve
-
Atrophic, hypertrophic or keloid scarring in clients with previous inflammatory acne
-
Facial, chest or back involvement
Practitioner Considerations and Referral
Severity, scarring risk and psychological impact matter as much as lesion count. NICE recommends specialist referral for diagnostic uncertainty, acne conglobata and nodulo-cystic acne, and consideration of referral where acne is causing scarring or persistent pigmentary change or has not responded to appropriate treatment pathways.
-
Establish whether the main presentation is comedonal, inflammatory, nodular/cystic or mixed
-
Ask about previous prescription treatment and response before suggesting additional products
-
Assess for post-inflammatory pigmentation and scarring, particularly where procedures are being considered
-
Consider pregnancy or breastfeeding status before discussing retinoid-containing pathways
-
Recognise significant distress or impact on wellbeing and signpost or refer appropriately
-
Do not delay medical referral for severe, rapidly worsening, nodulo-cystic or diagnostically uncertain acne
Supporting Acne-Prone Skin with Professional Skincare
A supportive skincare programme should be tolerable enough for the client to use consistently and should avoid unnecessary irritation that can worsen inflammation or post-inflammatory pigmentation.
-
Use a non-alkaline, skin-compatible cleansing approach and avoid aggressive scrubbing
-
Select non-comedogenic hydration and photoprotection where appropriate
-
Introduce acne-focused actives according to severity, tolerance, product status and professional scope
-
Avoid layering multiple irritating actives at the same time without a clear protocol
-
Review adherence, irritation and response before escalating the programme
-
Treat active acne and scar management as related but distinct clinical objectives
Healthxchange Portfolio Options for Acne & Blemish-Prone Skin
Acne and blemish-prone skin can involve excess sebum, follicular blockage, inflammation, sensitivity, post-inflammatory pigmentation and, in some clients, established scarring. The product or device pathway should therefore be chosen around the dominant presentation rather than assuming all acne-prone clients need the same programme.
Skincare and make-up
Obagi and Medik8 provide practitioner-led skincare options for congestion, blemishes, oiliness and uneven texture. Clinisept can support skin hygiene within appropriate professional protocols. Jane Iredale can be considered where a client needs complexion or camouflage support alongside their skin programme, while Epicutis may be useful when barrier support and hydration are also priorities.
Assessment and device-led pathways
OBSERV can support consultation and documentation by helping practitioners assess oiliness, congestion, redness, pigmentation and post-acne changes. MediLUX may form part of a device-led pathway where its use is suitable for the client and within the practitioner’s training. Potenza is more relevant when enlarged-looking pores, texture or established acne scarring become the treatment focus rather than active inflammatory acne.
Moderate-to-severe acne, nodulocystic disease, significant scarring risk or diagnostic uncertainty should remain within an appropriate medical pathway. Professional skincare should support, not replace, evidence-based acne management.
Build Your Acne Knowledge
The Healthxchange Academy Acne course covers triggers, pathogenesis, excess sebum, psychological factors and applying this knowledge to product and in-clinic offerings. Practitioners working across acne, pigmentation and redness can also use Obagi Best Practice and Advanced Learning to strengthen consultation and protocol decisions.
Related Skin Concerns